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Supplementary Figure S1 
Melting curve analysis for all primer pairs used in this study. 
The melting curves of the amplification products have been visualized using the Applied 
Biosystems ViiA 7 instrument (-ΔF/ΔT (fluorescence change/temperature change) vs. 
temperature (T)). Specificity of the used primer pairs have been confirmed by a single peak in 







Supplementary Figure S2 
Verification of primer specificity by agarose gel electrophoresis of PCR products. 
Specificity of primer pairs was verified by electrophoresis on a 2% (w/v) agarose gel. Pooled 
DNA samples have been run and single bands have been visualized using SYBR Safe DNA 
Gel Stain. The expected product sizes (given in brackets) have been confirmed using a 100 bp 







Supplementary Figure S3 
ΔCq method results of the seven candidate gene products that were not differentially 
expressed between experimental subgroups in the 2 h activation dataset. 
ΔCq variability in candidate reference gene products is shown as differences between the Cq 
values of the indicated pairs of gene products within each sample. For comparison, ΔCq for 
GAPDH mRNA, one of the transcripts that was differentially regulated between subgroups, is 







Supplementary Figure S4 
Determination of the optimal number of reference gene products by the geNorm algorithm in 
the 2 h activation dataset. 
Pairwise variation Vn/n+1 between two sets of genes with the n and n+1 most stable candidate 
reference gene products was calculated by geNorm. For V values below 0.15, the inclusion of 





Supplementary Table S1 
Pairwise comparisons of the Cq values of all candidate reference gene mRNAs between 








NV_activ -  
EM_activ 
gene estimate p value estimate p value estimate p value estimate p value 
ACTB 0.317 0.155 1.754 0 1.424 4.51E-14 -0.013 1.000 
B2M 0.299 0.069 0.243 0.125 0.319 0.020 0.375 0.008 
CASC3 0.012 1.000 0.383 0.097 0.041 0.994 -0.329 0.106 
GAPDH 1.565 0 0.864 4.97E-09 1.178 4.19E-14 1.879 0 
HMBS -0.451 0.013 0.570 2.16E-04 0.302 0.127 -0.719 1.07E-05 
HPRT1 0.140 0.499 0.407 0.001 0.516 9.72E-06 0.249 0.069 
IPO8 0.323 0.043 0.141 0.598 0.068 0.932 0.250 0.149 
PPIB 0.717 1.21E-09 0.197 0.232 0.315 0.014 0.834 9.12E-13 
RPLP0 0.131 0.887 0.258 0.422 0.194 0.660 0.067 0.979 
SDHA 0.142 0.713 -0.149 0.624 -0.269 0.132 0.023 0.998 
UBE2D2 -0.301 0.080 0.133 0.667 0.165 0.493 -0.269 0.109 
18S rRNA -0.113 0.770 0.029 0.995 0.139 0.647 -0.002 1.000 
 
Supplementary Table S2 
Combined stability values for all combinations of two genes for the 2 h activation dataset 
identified by NormFinder 
gene 1 gene 2 
combined 
stability 
SDHA IPO8 0.15 
SDHA CASC3 0.21 
SDHA UBE2D2 0.13 
SDHA B2M 0.19 
SDHA RPLP0 0.16 
SDHA 18S rRNA 0.14 
IPO8 CASC3 0.17 
IPO8 UBE2D2 0.08 
IPO8 B2M 0.22 
IPO8 RPLP0 0.14 
IPO8 18S rRNA 0.12 
CASC3 UBE2D2 0.24 
CASC3 B2M 0.20 
CASC3 RPLP0 0.21 
CASC3 18S rRNA 0.19 
UBE2D2 B2M 0.16 
UBE2D2 RPLP0 0.17 
UBE2D2 18S rRNA 0.14 
B2M RPLP0 0.17 
B2M 18S rRNA 0.16 




Supplementary Table S3 
ΔCq method results for the 2 h activation dataset including mean differences between the Cq 
values of pairs of gene transcripts and standard deviations 
vs. 























IPO8     -17.12 0.40 -2.68 0.46 -1.41 0.39 -5.26 0.55 -9.14 0.60 0.16 0.85 0.54 
18S rRNA 17.12 0.40     14.44 0.42 15.71 0.42 11.87 0.63 7.98 0.61 17.28 0.92 0.57 
UBE2D2 2.68 0.46 -14.44 0.42     1.27 0.47 -2.57 0.53 -6.46 0.52 2.84 1.01 0.57 
SDHA 1.41 0.39 -15.71 0.42 -1.27 0.47     -3.85 0.65 -7.73 0.55 1.57 1.00 0.58 
RPLP0 5.26 0.55 -11.87 0.63 2.57 0.53 3.85 0.65     -3.88 0.74 5.42 0.87 0.66 
B2M 9.14 0.60 -7.98 0.61 6.46 0.52 7.73 0.55 3.88 0.74     9.30 1.27 0.72 
CASC3 -0.16 0.85 -17.28 0.92 -2.84 1.01 -1.57 1.00 -5.42 0.87 -9.30 1.27     0.99 
 
Supplementary Table S4 
BestKeeper results for the 2 h activation dataset including standard deviation (SD) and 
coefficient of variance (CV)  
Gene SD CV [% Cp] coefficient of correlation 
18S rRNA 0.29 4.13 n. d. 
UBE2D2 0.33 1.54 0.680 
IPO8 0.35 1.46 0.787 
SDHA 0.36 1.61 0.647 
RPLP0 0.38 2.00 0.646 
B2M 0.49 3.30 0.592 
CASC3 0.65 2.68 0.402 
 
Supplementary Table S5 
ΔCq*M values for biologically relevant comparisons between experimental subgroups in the 
2 h activation dataset 
comparison groups 
ΔCq*M 
18S rRNA RPLP0 IPO8 SDHA UBE2D2 CASC3 B2M 
NV_no_activ - NV_activ 0.013 0.111 0.051 0.056 0.059 0.091 0.118 
EM_no_activ - EM_activ 0.051 0.104 0.021 0.100 0.065 0.023 0.144 
NV_no_activ - EM_no_activ 0.022 0.003 0.131 0.062 0.102 0.202 0.192 






Supplementary Table S6 
Ranking of candidate reference gene mRNAs according to their ΔCq*M values 
(Supplementary Table S5) for biologically relevant comparisons between experimental 
subgroups in the 2 h activation dataset 
comparison groups 
ranking according to ΔCq*M 
1 2 3 4 5 6 7 
NV_no_activ - NV_activ 18S rRNA IPO8 SDHA UBE2D2 CASC3 RPLP0 B2M 
EM_no_activ - EM_activ IPO8 CASC3 18S rRNA UBE2D2 SDHA RPLP0 B2M 
NV_no_activ - EM_no_activ RPLP0 18S rRNA SDHA UBE2D2 IPO8 B2M CASC3 
NV_activ - EM_activ RPLP0 18S rRNA SDHA UBE2D2 IPO8 B2M CASC3 
comprehensive ranking based  18S rRNA RPLP0 IPO8 SDHA UBE2D2 CASC3 B2M 
on geometric mean of 
individual ranking positions 
1.86 2.45 2.66 3.41 4.00 4.70 6.48 
 
Supplementary Table S7 
Ranking of candidate reference gene products in the 2 h activation dataset according to all 
different methods used 
Gene 
Ranking according to 
NormFinder ΔCq method BestKeeper geNorm ΔCq*M overall comprehensive ranking 
18S rRNA 1 2 1 3 1 1.43 
IPO8 2 1 3 1 3 1.78 
UBE2D2 4 3 2 4 5 3.44 
SDHA 5 4 4 2 4 3.64 
RPLP0 3 5 5 6 2 3.90 
B2M 6 6 6 5 7 5.97 






Supplementary Table S8 
Pairwise comparisons of the Cq values of all candidate reference gene mRNAs between 








NV_activ -  
EM_activ 
gene estimate p value estimate p value estimate p value estimate p value 
ACTB -0.032 0.994 2.353 0 2.067 0 -0.318 0.050 
B2M 0.615 0.007 1.428 5.63E-12 0.809 1.47E-04 -0.003 1.000 
CASC3 -0.096 0.965 0.950 2.10E-05 1.161 2.22E-08 0.115 0.938 
GAPDH 1.235 1.31E-10 3.867 0 2.685 0 0.053 0.993 
HMBS -0.159 0.812 2.989 0 3.011 0 -0.137 0.875 
HPRT1 0.379 0.072 2.798 0 2.499 0 0.080 0.962 
IPO8 0.331 0.026 1.062 2.95E-14 0.967 4.07E-14 0.236 0.200 
PPIB 0.864 1.65E-09 1.861 0 1.836 0 0.839 1.33E-08 
RPLP0 0.286 0.305 1.680 4.17E-14 1.501 3.35E-14 0.106 0.923 
SDHA 0.260 0.096 0.216 0.258 -0.052 0.968 -0.007 1.000 
UBE2D2 -0.341 0.027 0.622 9.99E-07 1.093 3.02E-14 0.131 0.696 
18S rRNA 0.004 1.000 0.105 0.907 0.079 0.952 -0.023 0.999 
 
Supplementary Table S9 
BestKeeper results for the 10 h activation dataset including standard deviation (SD) and 
coefficient of variance (CV)  
Gene SD CV [% Cp] 
18S rRNA 0.27 3.97 
SDHA 0.34 1.52 
UBE2D2 0.53 2.54 
IPO8 0.54 2.27 
CASC3 0.68 2.84 
B2M 0.69 4.82 
RPLP0 0.81 4.46 
PPIB 1.00 4.79 
ACTB 1.11 6.00 
HPRT1 1.33 5.34 
HMBS 1.50 5.53 






Supplementary Table S10 
Pairwise comparisons of the Cq values of all candidate reference gene mRNAs between 








NV_activ -  
EM_activ 
gene estimate p value estimate p value estimate p value estimate p value 
ACTB -0.232 0.348 2.797 0 2.879 0 -0.150 0.670 
B2M 0.249 0.127 0.698 2.76E-10 0.758 5.46E-12 0.308 0.024 
CASC3 0.170 0.729 0.861 1.93E-04 0.887 1.09E-04 0.197 0.603 
GAPDH 0.861 1.13E-09 4.586 0 3.273 0 -0.453 0.006 
HMBS -0.416 0.011 3.616 0 3.700 0 -0.332 0.076 
HPRT1 0.106 0.811 2.719 0 2.469 0 -0.144 0.652 
IPO8 0.088 0.892 1.125 3.69E-14 1.019 3.69E-14 -0.018 0.999 
PPIB 0.717 4.56E-07 2.108 0 2.015 0 0.623 2.17E-05 
RPLP0 0.152 0.341 1.978 0 1.873 0 0.048 0.951 
SDHA -0.162 0.639 0.228 0.295 0.221 0.289 -0.168 0.604 
UBE2D2 -0.517 1.16E-04 0.809 2.04E-09 1.117 3.35E-14 -0.209 0.346 
18S rRNA -0.139 0.408 0.045 0.976 0.056 0.954 -0.128 0.441 
 
Supplementary Table S11 
BestKeeper results for the 20 h activation dataset including standard deviation (SD) and 
coefficient of variance (CV)  
Gene SD CV [% Cp] 
18S rRNA 0.34 4.95 
SDHA 0.37 1.65 
CASC3 0.47 2.01 
UBE2D2 0.54 2.61 
IPO8 0.56 2.39 
B2M 0.57 3.95 
RPLP0 0.93 5.19 
PPIB 1.01 4.88 
HPRT1 1.24 4.95 
ACTB 1.41 7.84 
HMBS 1.79 6.74 
GAPDH 1.89 11.03 
 
